Concepedia

Thomas Pleli

TP

22

Publications

1.3K

Citations

18

H-Index

2009

Active since

Affiliations

Goethe University Frankfurt(Current)

University Hospital Frankfurt

Georg Speyer Haus

National Research Centre

Nanosystem (Russia)

Thomas Pleli is an author at Goethe University Frankfurt specializing in medicine, hepatocellular carcinoma, and pathology.

ORCID

Top concepts

Publications per year

2009–2020

22

Publications

22

High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis

Fabian Finkelmeier, Özge Canli, Andrea O. Tal et al. · European Journal of Cancer · 2016 · 200 citations

, , +13

Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

Verena Köberle, Thomas Pleli, Christian Schmithals et al. · PLoS ONE · 2013 · 193 citations · Full text

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

Verena Köberle, Bernd Kronenberger, Thomas Pleli et al. · European Journal of Cancer · 2013 · 183 citations

, , +10

Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection

Oliver Waidmann, Verena Bihrer, Thomas Pleli et al. · Journal of Viral Hepatitis · 2011 · 125 citations

Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma

Christian Schmithals, Verena Köberle, Hüdayi Korkusuz et al. · Cancer Research · 2015 · 64 citations · Full text

Rows per page

1–5 of 22